ADPT · Company research
Adaptive Biotechnologies Corporation (ADPT): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corporation (ADPT) Stock Price, News, Quote & History - Yahoo! Finance Canada | Adaptive Biotechnologies Corporation (ADPT) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| The results webcast is scheduled for 1:30 p.m. Pacific on Nov. 4. - Stock Titan | The results webcast is scheduled for 1:30 p.m. Pacific on Nov. 4. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| The COO exercised options and sold 35,643 Adaptive Biotechnologies (ADPT) shares. - Stock Titan | The COO exercised options and sold 35,643 Adaptive Biotechnologies (ADPT) shares. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies Corp (ADPT) Stock Down 3.5% but Still O - GuruFocus | Adaptive Biotechnologies Corp (ADPT) Stock Down 3.5% but Still O GuruFocus | View source ↗ | GuruFocus | Oct 12, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Stock Rated "Moderate Buy" by Sell-Side Brokerages - MarketBeat | Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Stock Rated "Moderate Buy" by Sell-Side Brokerages MarketBeat | View source ↗ | MarketBeat | Oct 12, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies (Nasdaq:ADPT) - Stock Analysis - Simply Wall Street | Adaptive Biotechnologies (Nasdaq:ADPT) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Oct 11, 2026 | neutral | 0 | 0.6 |
| An officer sells 6,444 shares at $30 each under a trading plan at Adaptive Biotechnologies (ADPT). - Stock Titan | An officer sells 6,444 shares at $30 each under a trading plan at Adaptive Biotechnologies (ADPT). Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| At $12.14 per share, Adaptive Biotechnologies (ADPT) COO exercised options on each of three share-sale dates. - Stock Titan | At $12.14 per share, Adaptive Biotechnologies (ADPT) COO exercised options on each of three share-sale dates. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies (ADPT) Stock Sees Modest Fair Value Lift On MRD Optimism - Yahoo Finance | Adaptive Biotechnologies (ADPT) Stock Sees Modest Fair Value Lift On MRD Optimism Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| Officer Susan Bobulsky proposes selling 6,444 Adaptive Biotechnologies (ADPT) shares. - Stock Titan | Officer Susan Bobulsky proposes selling 6,444 Adaptive Biotechnologies (ADPT) shares. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies (NASDAQ:ADPT) Stock: Insider Julie Rubinstein Sells 11,881 Shares - MarketBeat | Adaptive Biotechnologies (NASDAQ:ADPT) Stock: Insider Julie Rubinstein Sells 11,881 Shares MarketBeat | View source ↗ | MarketBeat | Oct 6, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies (ADPT) Stock May Be Trading At A Premium Following Its 477% Run - Simply Wall Street | Adaptive Biotechnologies (ADPT) Stock May Be Trading At A Premium Following Its 477% Run Simply Wall Street | View source ↗ | Simply Wall Street | Oct 2, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies (NasdaqGS:ADPT) Stock Price - Simply Wall Street | Adaptive Biotechnologies (NasdaqGS:ADPT) Stock Price Simply Wall Street | View source ↗ | Simply Wall Street | Oct 1, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rated "Buy" in New Coverage at The Goldman Sachs Group - MarketBeat | Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rated "Buy" in New Coverage at The Goldman Sachs Group MarketBeat | View source ↗ | MarketBeat | Sep 29, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies Corp (ADPT) Stock Down 3.1% but Still O - GuruFocus | Adaptive Biotechnologies Corp (ADPT) Stock Down 3.1% but Still O GuruFocus | View source ↗ | GuruFocus | Sep 28, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies (ADPT) Stock Could Be 26% Above Fair Value Despite Guideline Update - Yahoo Finance | Adaptive Biotechnologies (ADPT) Stock Could Be 26% Above Fair Value Despite Guideline Update Yahoo Finance | View source ↗ | Yahoo Finance | Sep 25, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies Stock: 5 Straight Green Days, Up 18% - Trefis | Adaptive Biotechnologies Stock: 5 Straight Green Days, Up 18% Trefis | View source ↗ | Trefis | Sep 21, 2026 | neutral | 0 | 0.6 |
| Adaptive Biotechnologies (ADPT) Stock May Be 22% Undervalued As Growth Hopes Build - Yahoo Finance | Adaptive Biotechnologies (ADPT) Stock May Be 22% Undervalued As Growth Hopes Build Yahoo Finance | View source ↗ | Yahoo Finance | Jul 24, 2026 | neutral | 0 | 0.6 |
| $ADPT stock is up 9% today. Here's what we see in our data. - Quiver Quantitative | $ADPT stock is up 9% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 24, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.